Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.

Key facts

Study ID

NCT07418125

Run by

Institute of Oncology Ljubljana

People needed

130

Starts

2024-02-07

Expected to finish

2028-12-31

Last updated by the study team

2026-02-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)
• Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C
• Adequate health status for neoadjuvant systemic treatment

You may not qualify if…

• Inflammatory breast cancer stage IV
• Luminal A, luminal B subtypes of non-inflammatory breast cancer
• Stages I-IIA breast cancer
• Inability to understand or communicate in Slovenian
• Inability to follow protocol instructions
• Inappropriate health status for chemotherapy treatment
• Primary treatment with surgery

Where it is running

• Institute of Oncology Ljubljana — Ljubljana, Slovenia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.